AMPH SG&A Expense Growth
Amphastar Pharmaceuticals Inc · SG&A Expense Growth
AMPH SG&A Expense Growth
Latest reported37.33%period ending
AMPH FY SG&A Growth (YoY) (0.00% → 37.33%)
Latest values, visible window
High-resolution chart · PNG
AMPH sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 37.3331% | |
| 17.5749% | |
| 20.7247% | |
| -3.3778% | |
| 5.7753% | |
| 3.2452% | |
| 8.7261% | |
| 13.9951% | |
| 7.6536% | |
| 0.6897% | |
| 16.35% | |
| 11.1561% | |
| 14.7619% | |
| 3.6551% | |
| 0% |